Ascendis Pharma A/S (Ascendis Pharma A/S) Accounts Payable & Accrued Expense

: $105.6 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

Ascendis Pharma A/S's quarterly accounts payable & accrued expense declined from Jun. 2023 ($138.6 Mil) to Sep. 2023 ($136.6 Mil) and declined from Sep. 2023 ($136.6 Mil) to Dec. 2023 ($105.6 Mil).

Ascendis Pharma A/S's annual accounts payable & accrued expense increased from Dec. 2021 ($67.4 Mil) to Dec. 2022 ($112.8 Mil) but then declined from Dec. 2022 ($112.8 Mil) to Dec. 2023 ($105.6 Mil).

Ascendis Pharma A/S Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ascendis Pharma A/S's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

30.98

27.01

67.36

112.84

105.63

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															112.84	148.09	138.56	136.64	105.63

Ascendis Pharma A/S Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.